UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Orion Capital Management LLC

Orion Capital Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 40.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 763 shares of the healthcare conglomerate’s stock after acquiring an additional 221 shares during the quarter. Orion Capital Management LLC’s holdings in UnitedHealth Group were worth $402,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its position in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after buying an additional 2,348,107 shares during the last quarter. Jennison Associates LLC grew its holdings in shares of UnitedHealth Group by 49.3% during the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after purchasing an additional 1,195,352 shares during the last quarter. Mawer Investment Management Ltd. boosted its position in UnitedHealth Group by 75.0% during the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after purchasing an additional 862,024 shares during the period. California Public Employees Retirement System grew its stake in UnitedHealth Group by 35.9% during the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after buying an additional 815,822 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its stake in UnitedHealth Group by 20.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock worth $1,879,245,000 after buying an additional 623,631 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on UNH shares. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Finally, Piper Sandler boosted their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Up 0.7 %

NYSE:UNH traded up $3.46 during trading hours on Wednesday, hitting $487.16. 1,732,294 shares of the company’s stock traded hands, compared to its average volume of 4,432,349. The firm has a market cap of $448.23 billion, a P/E ratio of 29.74, a P/E/G ratio of 1.42 and a beta of 0.54. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The stock’s fifty day moving average price is $484.44 and its two-hundred day moving average price is $513.42.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the firm posted $6.26 EPS. The business’s revenue was up 8.6% compared to the same quarter last year. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.54%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.